Immunomedics Inc. (IMMU)

HEALTH CARE: PHARMACEUTICALS
SIC: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

300 AMERICAN RD MORRIS PLAINS, NJ 07950

Immunomedics Inc. develops, manufactures and markets monoclonal antibody-based products for detection and treatment of cancer and other diseases. Focuses on therapeutic antibodies designed to carry radioisotopes, chemotherapeutic agents, toxins and other substances to a specific disease site or organ system.

Data based on most recent fiscal year report
Market Cap2.218 Billion Shares Outstanding152.02 Million Avg Volume4.687 Million
1-Yr BETA vs S&P TR Current Ratio1.29 Quick Ratio1.28
View SEC Filings from IMMU instead.
Q1 2019 All Institutions Hedge Funds 1
To trade IMMU now:
Filers who had this stock in their top 10: 11 7 (0.71%)
13F Filers holding this stock: 197 32 (3.26%)
Aggregate 13F shares on 03/31/2019: 174.047 Million 46.832 Million
Aggregate 13F shares on 12/31/2018: 162.285 Million 49.54 Million
Percent change: 7.25% -5.47%
Funds creating new positions: 47 8
Funds Adding to an existing position: 71 11
Funds closing out their position: 50 12
Funds reducing their position: 53 8
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding IMMU (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

750 Thousand total shares from 3 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MARKISON BRIAN A

  • Director
67,467 2019-05-15 0

KIRSCH ARTHUR S

0 2019-05-15 0

ARYEH JASON

  • Director
115,987 2019-05-14 0

AVORO CAPITAL ADVISORS LLC

AGHAZADEH BEHZAD

  • Director
  • SEE REMARKSSEE REMARKS
18,468,310 2019-05-13 2

FRICKER WILLIAM PRINCIPAL ACCOUNTING OFFICER

  • Officer
0 2019-04-04 4

DELANEY BRENDAN CHIEF COMMERCIAL OFFICER

  • Officer
0 2019-03-14 2

IANNONE ROBERT CHIEF MEDICAL OFFICER

  • Officer
0 2019-03-14 2

MALIK USAMA CHIEF FINANCIAL & BUSINESS OFF

  • Officer
0 2019-03-14 2

ROSENBERG MORRIS CHIEF TECHNOLOGY OFFICER

  • Officer
0 2019-03-14 2

FREEDBERG JARED GENERAL COUNSEL

  • Officer
0 2019-03-14 3

ANDREWS KURT J. CHIEF HUMAN RESOURCES OFFICER

  • Officer
0 2019-03-14 2

CANUTE SCOTT A

  • Director
0 2019-03-05 1

BALL BRYAN CHIEF QUALITY OFFICER

  • Officer
0 2019-03-05 2

DUNCAN BARBARA GAYLE

  • Director
0 2019-03-05 2

BAUM CHARLES M PRESIDENT & CEO

66,041 2019-02-25 2

PFREUNDSCHUH PETER P. CHIEF FINANCIAL OFFICER

  • Officer
0 2019-01-26 0

FORRESTER ROBERT PRESIDENT AND CEO

  • Officer
  • Director
0 2019-01-03 0

HUTT PETER BARTON

  • Director
3,924 2018-12-07 0

PEHL MICHAEL F. PRESIDENT AND CEO

  • Officer
0 2018-09-14 1

ZUERBLIS KENNETH J

  • Director
45,121 2018-06-21 0

ISLAM KHALID

  • Director
0 2018-06-08 0

GOLDENBERG DAVID M

  • Director
7,387,537 2018-02-28 0

AGHAZADEH BEHZAD

  • Director
  • 10% Owner
  • SEE REMARKS
16,064,461 2017-11-14 1

VENBIO SELECT ADVISOR LLC

  • Director
  • 10% Owner
  • SEE REMARKS
16,064,461 2017-11-14 2

GOLDENBERG CYNTHIA L

  • Director
5,906,233 2017-08-31 0

GARONE MICHAEL CHIEF FINANCIAL OFFICER

  • Officer
0 2017-07-03 0

STARK DON C

  • Director
No longer subject to file 2017-06-30 0

COX GEOFFREY F

  • Director
0 2017-05-18 0

OLIVER BOB

  • Director
0 2017-01-08 0

PAETZOLD MARY E

  • Director
78,325 2016-12-02 0

SHERMAN RICHARD L.

  • Director
No longer subject to file 2015-12-01 0

COLEMAN MORTON VICE PRESIDENT

  • Officer
5,568,166 2014-02-21 0

LOCASTRO MARCELLA

  • Director
No longer subject to file 2013-12-04 0

GORMAN GERARD G SVP, FIN. , AND CFO

  • Officer
0 2013-08-16 0

WOLYNIC EDWARD T

  • Director
6,667 2009-12-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

AVORO CAPITAL ADVISORS LLC - Director SEE REMARKS see footnotes

AGHAZADEH BEHZAD - Director SEE REMARKS see footnotes

2019-05-15 P 125,000 $14.95 a 18,464,461 18,468,310.00 indirect

AVORO CAPITAL ADVISORS LLC - Director SEE REMARKS see footnotes

AGHAZADEH BEHZAD - Director SEE REMARKS see footnotes

2019-05-14 P 125,000 $15.40 a 18,339,461 18,468,310.00 indirect

AVORO CAPITAL ADVISORS LLC - Director SEE REMARKS see footnotes

AGHAZADEH BEHZAD - Director SEE REMARKS see footnotes

2019-05-13 P 500,000 $15.07 a 18,214,461 18,468,310.00 indirect

FRICKER WILLIAM - Officer PRINCIPAL ACCOUNTING OFFICER

2019-04-04 A 15,000 a 15,000 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments